Keyphrases
Anemia
73%
RhEPO
72%
Multiple Myeloma
69%
Chemotherapy
56%
Platelet Function
54%
Acute Leukemia
48%
Presenting Symptoms
43%
Clinical picture
39%
Bleeding
39%
Platelet Aggregation
36%
Fever of Unknown Origin
36%
Myeloma
36%
Clinical Significance
36%
Community Hospital
36%
Clinical Experience
36%
Malignancy
36%
COVID-19 Patients
30%
Blood Transfusion Requirement
29%
Chronic Myeloid Leukemia
27%
Leukemia
27%
Israel
26%
Erythropoietin
24%
Young Patients
24%
Hospitalized Patients
24%
Cyclophosphamide
22%
Myeloproliferative Neoplasms
22%
Risk Factors
22%
Deep Vein Thrombosis
21%
Essential Thrombocythemia
21%
Complete Remission
21%
Anemia Treatment
20%
Hemoglobin Level
20%
Allogeneic Blood Transfusion
18%
Vomiting
18%
Secondary Myelodysplastic Syndrome
18%
Amyloidosis
18%
Chloro
18%
Liver Cirrhosis
18%
Warm Autoantibody
18%
Single Institution
18%
Brachial
18%
Cryoglobulinemia
18%
Clinical Characteristics
18%
Splenectomy
18%
Myelodysplastic Syndrome
18%
Hairy Cell Leukemia
18%
Adenosine
18%
Interferon-α (IFN-α)
18%
Cunnilingus
18%
Vulvar Hematoma
18%
Medicine and Dentistry
Disease
100%
Thrombocyte Function
50%
Infection
50%
Acute Leukemia
49%
Anemia
45%
Symptom
45%
Bleeding
37%
Cancer
37%
Myeloma
36%
Myelodysplastic Syndrome
36%
COVID-19
36%
Fever of Unknown Origin
36%
Clinical Significance
36%
Thrombocyte Aggregation
36%
Multiple Myeloma
35%
Recombinant Erythropoietin
32%
Sulfhemoglobinemia
30%
Low Drug Dose
26%
Apoplexy
24%
Evans Syndrome
22%
Myeloproliferative Disorder
22%
Interferon
21%
Deep Vein Thrombosis
21%
Internal Medicine
20%
Burkitt's Lymphoma
18%
Pleura Effusion
18%
Hyperbaric Medicine
18%
Chemoradiotherapy
18%
Splenectomy
18%
Amyloidosis
18%
Hairy Cell Leukemia
18%
Cryoglobulinemia
18%
Cunnilingus
18%
Sex Difference
18%
Breast Carcinoma
18%
Adenosine
18%
Positron Emission Tomography
18%
Non Prescription Drug
18%
Hepatitis C
18%
Erythropoietin
18%
Large-Cell Lymphoma
18%
Critical Illness
18%
Membranoproliferative Glomerulonephritis
18%
Vasospasm
18%
Acute Liver Failure
18%
Systemic Lupus Erythematosus
18%
Allergic Response
18%
B-Cell Chronic Lymphocytic Leukemia
18%
Liver Cirrhosis
18%
Pure Red Cell Aplasia
18%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
72%
Multiple Myeloma
71%
Recombinant Erythropoietin
68%
Chemotherapy
68%
Disease
54%
Acute Leukemia
36%
Myeloma
36%
Erythropoietin
34%
Infection
33%
Hematologic Disease
30%
Pleura Effusion
18%
Amyloidosis
18%
Hodgkin Disease
18%
Cyclophosphamide
18%
West Nile Fever
18%
Rituximab
18%
Non Prescription Drug
18%
Allergic Reaction
18%
Nausea and Vomiting
18%
Chemoradiation Therapy
18%
Idiopathic Thrombocytopenic Purpura
18%
Pyrexia Idiopathica
18%
Ischemic Heart Disease
18%
Granisetron
18%
Chronic Lymphatic Leukemia
18%
Myelodysplastic Syndrome
18%
Silastic
18%
Myelitis
18%
Inflammation
18%
Biological Marker
18%
Thrombotic Thrombocytopenic Purpura
18%
Acute Appendicitis
18%
Zofran
18%
Cohort Study
18%
Probiotic Agent
18%
Glucose 6 Phosphate Dehydrogenase Deficiency
18%
Antibiotic Associated Diarrhea
18%
Naphthalene
18%
Remission
16%
Triacylglycerol
13%
Side Effect
12%
Clinical Trial
11%
Diarrhea
11%
Malignant Neoplasm
10%
Serotonin Antagonist
9%
Syndrome
9%
Low Density Lipoprotein Cholesterol
9%
Cytarabine
9%
Diabetes Mellitus
9%
Chlorhexidine Gluconate
9%